Copyright Reports & Markets. All rights reserved.

Global H1N1 Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of H1N1 Vaccines
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global H1N1 Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Intramuscular Vaccines
    • 1.3.3 Intranasal Vaccines
    • 1.3.4 Intradermal Vaccines
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global H1N1 Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Influenza
    • 1.4.3 Meningococcal
    • 1.4.4 Cervical Cancer
    • 1.4.5 Pneumococcal
    • 1.4.6 Hepatitis
    • 1.4.7 Measles
    • 1.4.8 Mumps
    • 1.4.9 Rubella
    • 1.4.10 Others
  • 1.5 Global H1N1 Vaccines Market Size & Forecast
    • 1.5.1 Global H1N1 Vaccines Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global H1N1 Vaccines Sales Quantity (2019-2030)
    • 1.5.3 Global H1N1 Vaccines Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott H1N1 Vaccines Product and Services
    • 2.1.4 Abbott H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Baxter International
    • 2.2.1 Baxter International Details
    • 2.2.2 Baxter International Major Business
    • 2.2.3 Baxter International H1N1 Vaccines Product and Services
    • 2.2.4 Baxter International H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Baxter International Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi H1N1 Vaccines Product and Services
    • 2.3.4 Sanofi H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 GSK
    • 2.4.1 GSK Details
    • 2.4.2 GSK Major Business
    • 2.4.3 GSK H1N1 Vaccines Product and Services
    • 2.4.4 GSK H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 GSK Recent Developments/Updates
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer H1N1 Vaccines Product and Services
    • 2.5.4 Pfizer H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Pfizer Recent Developments/Updates
  • 2.6 Mitsubishi Tanabe Pharma
    • 2.6.1 Mitsubishi Tanabe Pharma Details
    • 2.6.2 Mitsubishi Tanabe Pharma Major Business
    • 2.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Product and Services
    • 2.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
  • 2.7 Hualan Biological Engineering
    • 2.7.1 Hualan Biological Engineering Details
    • 2.7.2 Hualan Biological Engineering Major Business
    • 2.7.3 Hualan Biological Engineering H1N1 Vaccines Product and Services
    • 2.7.4 Hualan Biological Engineering H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Hualan Biological Engineering Recent Developments/Updates
  • 2.8 Cipla
    • 2.8.1 Cipla Details
    • 2.8.2 Cipla Major Business
    • 2.8.3 Cipla H1N1 Vaccines Product and Services
    • 2.8.4 Cipla H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Cipla Recent Developments/Updates
  • 2.9 Merck
    • 2.9.1 Merck Details
    • 2.9.2 Merck Major Business
    • 2.9.3 Merck H1N1 Vaccines Product and Services
    • 2.9.4 Merck H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Merck Recent Developments/Updates
  • 2.10 Sinovac Biotech
    • 2.10.1 Sinovac Biotech Details
    • 2.10.2 Sinovac Biotech Major Business
    • 2.10.3 Sinovac Biotech H1N1 Vaccines Product and Services
    • 2.10.4 Sinovac Biotech H1N1 Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Sinovac Biotech Recent Developments/Updates

3 Competitive Environment: H1N1 Vaccines by Manufacturer

  • 3.1 Global H1N1 Vaccines Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global H1N1 Vaccines Revenue by Manufacturer (2019-2024)
  • 3.3 Global H1N1 Vaccines Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of H1N1 Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 H1N1 Vaccines Manufacturer Market Share in 2023
    • 3.4.2 Top 6 H1N1 Vaccines Manufacturer Market Share in 2023
  • 3.5 H1N1 Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 H1N1 Vaccines Market: Region Footprint
    • 3.5.2 H1N1 Vaccines Market: Company Product Type Footprint
    • 3.5.3 H1N1 Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global H1N1 Vaccines Market Size by Region
    • 4.1.1 Global H1N1 Vaccines Sales Quantity by Region (2019-2030)
    • 4.1.2 Global H1N1 Vaccines Consumption Value by Region (2019-2030)
    • 4.1.3 Global H1N1 Vaccines Average Price by Region (2019-2030)
  • 4.2 North America H1N1 Vaccines Consumption Value (2019-2030)
  • 4.3 Europe H1N1 Vaccines Consumption Value (2019-2030)
  • 4.4 Asia-Pacific H1N1 Vaccines Consumption Value (2019-2030)
  • 4.5 South America H1N1 Vaccines Consumption Value (2019-2030)
  • 4.6 Middle East and Africa H1N1 Vaccines Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global H1N1 Vaccines Sales Quantity by Type (2019-2030)
  • 5.2 Global H1N1 Vaccines Consumption Value by Type (2019-2030)
  • 5.3 Global H1N1 Vaccines Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global H1N1 Vaccines Sales Quantity by Application (2019-2030)
  • 6.2 Global H1N1 Vaccines Consumption Value by Application (2019-2030)
  • 6.3 Global H1N1 Vaccines Average Price by Application (2019-2030)

7 North America

  • 7.1 North America H1N1 Vaccines Sales Quantity by Type (2019-2030)
  • 7.2 North America H1N1 Vaccines Sales Quantity by Application (2019-2030)
  • 7.3 North America H1N1 Vaccines Market Size by Country
    • 7.3.1 North America H1N1 Vaccines Sales Quantity by Country (2019-2030)
    • 7.3.2 North America H1N1 Vaccines Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe H1N1 Vaccines Sales Quantity by Type (2019-2030)
  • 8.2 Europe H1N1 Vaccines Sales Quantity by Application (2019-2030)
  • 8.3 Europe H1N1 Vaccines Market Size by Country
    • 8.3.1 Europe H1N1 Vaccines Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe H1N1 Vaccines Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific H1N1 Vaccines Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific H1N1 Vaccines Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific H1N1 Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific H1N1 Vaccines Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific H1N1 Vaccines Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America H1N1 Vaccines Sales Quantity by Type (2019-2030)
  • 10.2 South America H1N1 Vaccines Sales Quantity by Application (2019-2030)
  • 10.3 South America H1N1 Vaccines Market Size by Country
    • 10.3.1 South America H1N1 Vaccines Sales Quantity by Country (2019-2030)
    • 10.3.2 South America H1N1 Vaccines Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa H1N1 Vaccines Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa H1N1 Vaccines Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa H1N1 Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa H1N1 Vaccines Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa H1N1 Vaccines Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 H1N1 Vaccines Market Drivers
  • 12.2 H1N1 Vaccines Market Restraints
  • 12.3 H1N1 Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of H1N1 Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of H1N1 Vaccines
  • 13.3 H1N1 Vaccines Production Process
  • 13.4 H1N1 Vaccines Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 H1N1 Vaccines Typical Distributors
  • 14.3 H1N1 Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global H1N1 Vaccines market size was valued at USD 4708.9 million in 2023 and is forecast to a readjusted size of USD 5797.1 million by 2030 with a CAGR of 3.0% during review period.
    A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the H1N1 Vaccines industry chain, the market status of Influenza (Intramuscular Vaccines, Intranasal Vaccines), Meningococcal (Intramuscular Vaccines, Intranasal Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of H1N1 Vaccines.
    Regionally, the report analyzes the H1N1 Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global H1N1 Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the H1N1 Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the H1N1 Vaccines industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Intramuscular Vaccines, Intranasal Vaccines).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the H1N1 Vaccines market.
    Regional Analysis: The report involves examining the H1N1 Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the H1N1 Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to H1N1 Vaccines:
    Company Analysis: Report covers individual H1N1 Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards H1N1 Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Influenza, Meningococcal).
    Technology Analysis: Report covers specific technologies relevant to H1N1 Vaccines. It assesses the current state, advancements, and potential future developments in H1N1 Vaccines areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the H1N1 Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    H1N1 Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Intramuscular Vaccines
    Intranasal Vaccines
    Intradermal Vaccines
    Market segment by Application
    Influenza
    Meningococcal
    Cervical Cancer
    Pneumococcal
    Hepatitis
    Measles
    Mumps
    Rubella
    Others
    Major players covered
    Abbott
    Baxter International
    Sanofi
    GSK
    Pfizer
    Mitsubishi Tanabe Pharma
    Hualan Biological Engineering
    Cipla
    Merck
    Sinovac Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe H1N1 Vaccines product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of H1N1 Vaccines, with price, sales, revenue and global market share of H1N1 Vaccines from 2019 to 2024.
    Chapter 3, the H1N1 Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the H1N1 Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and H1N1 Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of H1N1 Vaccines.
    Chapter 14 and 15, to describe H1N1 Vaccines sales channel, distributors, customers, research findings and conclusion.

    Buy now